89bio, Inc. (ETNB)

89bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.08	126.06	316.16	55.26	52.43	98.18
Short-Term Investments	432.09	313.9	262.71	132.91	98.29	106.45
Cash & Short-Term Investments	561.16	439.96	578.87	188.16	150.72	204.63
Cash Growth	5.60%	-24.00%	207.65%	24.84%	-26.35%	119.24%
Other Current Assets	40.36	36.5	14.66	7.92	11.26	5.57
Total Current Assets	601.52	476.45	593.53	196.08	161.98	210.2
Net Property, Plant & Equipment	1.33	1.6	2.34	0.46	0.15	0.17
Other Long-Term Assets	0.63	0.64	0.4	0.29	0.29	0.71
Total Assets	603.49	478.69	596.27	196.82	162.42	211.07

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	14.66	15.38	8.59	12.5	6.84	2.07
Accrued Expenses	24.17	20.02	20.53	11.94	10.19	6.05
Current Portion of Long-Term Debt	-	-	-	-	2.5	-
Current Portion of Leases	0.78	0.73	0.5	0.17	-	-
Total Current Liabilities	39.61	36.13	29.61	24.61	19.54	8.11
Long-Term Debt	36.16	35.73	24.8	20.19	16.9	-
Long-Term Leases	0.68	1.09	1.82	0.19	-	-
Other Long-Term Liabilities	5.31	4.95	3.74	-	0.03	-
Total Long-Term Liabilities	42.14	41.77	30.35	20.38	16.93	-
Total Liabilities	81.75	77.9	59.96	44.99	36.47	8.11

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.15	0.12	0.09	0.05	0.02	0.02
Additional Paid-in Capital	1,529	1,225	993.46	467.37	339.22	326.05
Accumulated Other Comprehensive Income	0.12	0.56	0.19	-0.35	-0.06	-0.01
Retained Earnings	-1,007	-824.51	-457.43	-315.24	-213.22	-123.1
Shareholders' Equity	521.73	400.79	536.31	151.83	125.96	202.96
Total Liabilities & Equity	603.49	478.69	596.27	196.82	162.42	211.07

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	37.62	37.55	27.11	20.55	19.4	0
Net Cash (Debt)	523.55	402.41	551.76	167.61	131.32	204.63
Net Cash Growth	3.87%	-27.07%	229.19%	27.64%	-35.82%	119.24%
Net Cash Per Share	3.97	3.84	7.75	4.82	6.53	12.72
Book Value	521.73	400.79	536.31	151.83	125.96	202.96
Book Value Per Share	3.96	3.83	7.54	4.36	6.27	12.62
Tangible Book Value	521.73	400.79	536.31	151.83	125.96	202.96
Tangible Book Value Per Share	3.96	3.83	7.54	4.36	6.27	12.62

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jun 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error